









Markets
/
Stocks
/
nasdaq-ntrb
/

Nutriband Inc

NTRB

4.350USD

+0.005+0.12%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

52.88MMarket Cap

LossP/E TTM



Nutriband Inc

4.350

+0.005+0.12%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Nutriband Inc

Currency: USD Updated: 2026-02-06

Key Insights

Nutriband Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 118 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 15.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nutriband Inc's Score

Industry at a Glance

Industry Ranking

118 / 205

Overall Ranking

308 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Nutriband Inc Highlights

StrengthsRisks

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Growing

The company is in a growing phase, with the latest annual income totaling USD 2.14M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.14M.

Overvalued

The company’s latest PE is -1.43, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 355.48K shares, decreasing 22.28% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 202.74K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.68.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

15.000

Target Price

+245.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Nutriband Inc is 6.07, ranking 174 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 346.06K, representing a year-over-year decrease of 46.41%, while its net profit experienced a year-over-year decrease of 184.18%.

Score

Industry at a Glance

Previous score

6.07

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.97

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.65

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

3.62

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Nutriband Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Nutriband Inc is 5.76, ranking 179 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.43, which is -2.99% below the recent high of -1.38 and -883.86% above the recent low of -14.04.

Score

Industry at a Glance

Previous score

5.76

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 118/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Nutriband Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 15.00, with a high of 15.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

15.000

Target Price

+245.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Nutriband Inc

NTRB

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Nutriband Inc is 6.71, ranking 99 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.83 and the support level at 4.02, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.72

Change

-0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.030

Sell

RSI(14)

43.618

Neutral

STOCH(KDJ)(9,3,3)

21.474

Sell

ATR(14)

0.307

Low Volatility

CCI(14)

-105.416

Sell

Williams %R

80.769

Oversold

TRIX(12,20)

-0.014

Sell

StochRSI(14)

10.074

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

4.453

Sell

MA10

4.605

Sell

MA20

4.512

Sell

MA50

4.638

Sell

MA100

5.697

Sell

MA200

6.344

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Nutriband Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 2.92%, representing a quarter-over-quarter increase of 0.20%. The largest institutional shareholder is The Vanguard, holding a total of 202.74K shares, representing 1.67% of shares outstanding, with 7.08% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Botgros (Vitalie)

3.22M

+4.28%

TII Jet Services, LDA

1.81M

+36.66%

Sheridan (Gareth)

1.76M

Glinka (Serguei)

1.12M

+35.64%

Melnik (Serguei)

939.42K

+14.50%

The Vanguard Group, Inc.

Star Investors

202.74K

+1.56%

Goodman (Gerald)

86.33K

Geode Capital Management, L.L.C.

59.94K

-5.80%

Smith (Allan)

36.91K

-11.93%

Patrick (Jeff)

36.61K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Nutriband Inc is 2.17, ranking 162 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.79. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.